![Angiodema: Gene therapy treats painful hereditary disorder](https://i0.wp.com/contentedreader.com/wp-content/uploads/2024/02/109313549_gettyimages-1040300740.jpg?resize=768%2C432&ssl=1)
In the trial, published in the New England Journal of Medicine, angiodema symptoms were reduced by 95% among a small group of patients from the UK, New Zealand, and the Netherlands given a single infusion – targeted at cells in the liver – to reduce the KLKB1 gene’s ability to produce plasma prekallikrein.